Self-Validated Homogeneous Immunoassay by Single Nanoparticle in-Depth Scrutinization
Zili Huang1, Chaoqun Wang1, Rui Liu1
1Key Laboratory of Green Chemistry & Technology, Ministry of Education, College of Chemistry , Sichuan University , Chengdu , Sichuan 610064 , China.
Analytical Chemistry
|January 9, 2020
Summary
This study introduces a self-validated homogeneous immunoassay for accurate disease biomarker analysis. It overcomes matrix effects using single gold nanoparticles and ICP-MS, ensuring reliable clinical results.
Area of Science:
- Analytical Chemistry
- Biomarker Detection
- Nanotechnology
Background:
- Homogeneous immunoassays offer convenient clinical biomarker analysis but suffer from matrix effect-induced inaccuracies.
- Accurate quantification in complex biological samples remains a challenge for current homogeneous immunoassay methods.
Purpose of the Study:
- To develop a self-validated homogeneous immunoassay for accurate disease biomarker quantification.
- To address and mitigate the matrix effect in homogeneous immunoassays.
Main Methods:
- Simultaneous analysis of single gold nanoparticle frequency and intensity using single particle inductively coupled plasma mass spectrometry (ICP-MS).
- Development of a self-validation mechanism through correlated analytical modes of ICP-MS.
- Application of the method to human serum samples.
Main Results:
- The two ICP-MS analytical modes demonstrated good correlation, establishing a self-validation mechanism.
- The proposed method achieved linear ranges of 2 orders of magnitude and picomolar (pM) level limits of detection (LODs).
- Successful demonstration in human serum samples, showing results consistent with routine clinical methods.
Conclusions:
- The self-validated homogeneous immunoassay effectively guarantees accurate quantification by overcoming matrix effects.
- The high matrix effect tolerance of ICP-MS combined with the self-validation strategy enables reliable biomarker analysis in clinical samples.
- This approach offers a robust solution for routine clinical diagnostics requiring precise immunoassay results.


